1. AB0076 Jak inhibitor baricitinib modulates human innate and adaptive immune system. (12th June 2018) Authors: Kubo, S.; Nakayamada, S.; Ma, X.; Lee, S.; Yamagata, K.; Nakano, K.; Iwata, S.; Hanami, K.; Fukuyo, S.; Miyagawa, I.; Tamaki, Y.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0415 A New Prognostic Factor to Sustain Remission for 2 Years after Adalimumab Discontinuation & the Clinical Outcomes in RA Patients: Honor Study 2-Years Results. (10th June 2014) Authors: Tanaka, Y.; Hirata, S.; Kubo, S.; Fukuyo, S.; Hanami, K.; Sawamukai, N.; Nakano, K.; Nakayamada, S.; Yamaoka, K.; Saito, K. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0095 Diversity of The Peripheral Immunological Phenotype after Biologic DMARD Therapy in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Nakayamada, S.; Kubo, S.; Yoshikawa, M.; Miyazaki, Y.; Yunoue, N.; Iwata, S.; Nakano, K.; Saito, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0096 Predictive Value of The Multi-Biomarker Disease Activity (MBDA) Score for Flare and Sustained Remission in The Honor Study. (15th July 2016) Authors: Hirata, S.; Tang, S.; Hwang, C.C.; Miyagawa, I.; Kubo, S.; Nakano, K.; Nakayamada, S.; Saito, K.; Defranoux, N.A.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0102 SERUM TNFΑ LEVELS AT 24 HOURS AFTER FIRST ADMINISTRATION OF CERTOLIZUMAB PEGOL PREDICT EFFECTIVENESS AT WEEK 12 IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM TSUBAME STUDY (UMIN ID:0002381). (2nd June 2020) Authors: Miyazaki, Y.; Nakano, K.; Nakayamada, S.; Kubo, S.; Iwata, S.; Hanami, K.; Fukuyo, S.; Miyagawa, I.; Yamaguchi, A.; Kawabe, A.; Kazuyoshi, S.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0170 The Comparative Effectiveness of Five Biologics as Second-Line Use for Patients with Rheumatoid Arthritis in Daily Clinical Practice. (9th June 2015) Authors: Saito, K.; Nakano, K.; Nakayamada, S.; Hirata, S.; Kubo, S.; Fukuyo, S.; Miyagawa, I.; Sawamukai, N.; Hanami, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0223 The Best Selection of Second Biologics for Patients with Rheumatoid Arthritis in Daily Clinical Practice. (15th July 2016) Authors: Saito, K.; Nakano, K.; Nakayamada, S.; Kubo, S.; Miyagawa, I.; Hirata, S.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0251 Comparison of lipid profile including high molecular weight adiponectin (HMW-AN) after treatment with three different biologics in the patients with bio-naïve rheumatoid arthritis (RA). (23rd January 2014) Authors: Saito, K.; Hanami, K.; Hirata, S.; Kubo, S.; Nawata, M.; Yamaoka, K.; Nakayamada, S.; Nakano, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0474 The Three-Year Outcome of Infliximab (IFX), an Anti-TNF-α Antibody, in Patients with Refractory Intestinal-BehÇEt's Disease (BD). (10th June 2014) Authors: Saito, K.; Miyagawa, I.; Yamaoka, K.; Nakayamada, S.; Nakano, K.; Hirata, S.; Fukuyo, S.; Kubo, S.; Hanami, K.; Sawamukai, N.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0027 Abnormal B Cell Activation through Cellular Metabolic Reprogramming and Its Relevance To The Pathogenesis of SLE. (15th July 2016) Authors: Torigoe, M.; Iwata, S.; Sakata, K.; Nakayamada, S.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗